Literature DB >> 15648066

Drug-induced hypersensitivity syndrome due to cyanamide associated with multiple reactivation of human herpesviruses.

Naoko Mitani1, Michiko Aihara, Yuko Yamakawa, Masako Yamada, Norihiko Itoh, Nobuhisa Mizuki, Zenro Ikezawa.   

Abstract

Drug-induced hypersensitivity syndrome (DIHS), characterized by serious adverse systemic reactions in addition to skin rash, has unknown pathogenesis. Its association with human herpesvirus (HHV), mainly HHV-6, has been reported recently. A 46-year-old Japanese man is described in whom a generalized eruption developed about 1 month after taking cyanamide, a drug for alcoholism. This was associated with the following manifestations: high fever, lymphadenopathy, facial edema, marked leukocytosis with eosinophilia and atypical lymphocytes, lymphocytopenia, liver and renal dysfunction, and low IgG level. He was treated with 8 mg betamethasone daily and his condition improved, but he needed low-dose corticosteroid for almost 1 year because of several episodes of recurrence. HHV-6, HHV-7, herpes simplex virus (HSV), and cytomegalovirus (CMV) specific IgG titers showed more than a four-fold rise sequentially. Significant numbers of copies of HHV-6 and HHV-7 DNA were detected in the peripheral white blood cells by real-time polymerase chain reaction (PCR). HHV-6 and CMV DNA were detected in the serum by nested PCR. A patch test for cyanamide was positive. The diagnosis of DIHS due to cyanamide, which has never been reported as a causal drug of DIHS, accompanied by reactivation of not only HHV-6, but also HHV-7, CMV, and HSV, was made. Disturbance of the immune system was suggested by the persistent low level of IgG, and consecutive viral reactivation may have participated in the prolonged course in this case. 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15648066     DOI: 10.1002/jmv.20295

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  5 in total

1.  Development of a human herpesvirus 6 species-specific immunoblotting assay.

Authors:  Yuki Higashimoto; Akane Ohta; Yukihiro Nishiyama; Masaru Ihira; Ken Sugata; Yoshizo Asano; Daniel L Peterson; Dharam V Ablashi; Paolo Lusso; Tetsushi Yoshikawa
Journal:  J Clin Microbiol       Date:  2012-01-25       Impact factor: 5.948

Review 2.  Characterizing DRESS syndrome recurrence: a systematic review.

Authors:  Ajay N Sharma; Samantha Shwe; Vignesh Ravi; Melanie Miller; Natasha A Mesinkovska; Nathan W Rojek; Scott Worswick
Journal:  Arch Dermatol Res       Date:  2021-09-10       Impact factor: 3.033

3.  Human herpesvirus 6 subtype A-associated myocarditis with 'apical ballooning'.

Authors:  Boris Bigalke; Karin Klingel; Andreas E May; Reinhard Kandolf; Meinrad Gawaz Gawaz
Journal:  Can J Cardiol       Date:  2007-04       Impact factor: 5.223

4.  The Link between Hypersensitivity Syndrome Reaction Development and Human Herpes Virus-6 Reactivation.

Authors:  Joshua C Pritchett; Radu M Nanau; Manuela G Neuman
Journal:  Int J Hepatol       Date:  2012-05-16

Review 5.  Genomic Risk Factors Driving Immune-Mediated Delayed Drug Hypersensitivity Reactions.

Authors:  Yueran Li; Pooja Deshpande; Rebecca J Hertzman; Amy M Palubinsky; Andrew Gibson; Elizabeth J Phillips
Journal:  Front Genet       Date:  2021-04-16       Impact factor: 4.599

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.